Immunotherapy Weekly articles from August 2002

Immunotherapy Weekly archives from August 2002

Study shows asthma training programs improve outcomes.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Roxanna Guilford-Blake, senior medical writer - Professional asthma training programs for clinicians can significantly improve patient outcomes, according Margaret H. Lester, RN, MSN, FNP, director...

Heart-felt stress can be more dangerous to immune system.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- People who react to stress more in their heart than in their vascular system are more likely to suffer immune system problems, according to a new study. Public speaking and similar stress-inducing...

Children with asthma plagued by smokers and pets.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Two important triggers of asthma attacks are rarely removed from homes of children with asthma, according to a new study by researchers at National Jewish Medical and Research Center. The study,...

Immune factor works with interferon to treat hepatitis B virus nonresponders.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - When combined with interferon, a common immune system response factor may be just as effective as lamivudine and interferon combination therapy for treating...

Novel selective T-cell depletion method may reduce graft-versus-host disease risk.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Canada have developed a novel technique for selectively destroying activated T-cells, which they say could help prevent graft-versus-host disease...

Consumers find food allergen labeling confusing, inconsistent.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Ninety-three percent of parents of children with milk allergy cannot correctly identify labels indicating milk on an ingredient statement, and 38 out of 82 parents of children with peanut allergy failed...

Clarinex Reditabs approved for indoor and outdoor allergies and chronic idiopathic urticaria.(Brief Article)
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corp. (SGP) announced that Clarinex 5 mg Reditabs, a rapidly disintegrating tablet formulation of the nonsedating antihistamine desloratadine, has been approved by the U.S. Food and Drug...

Drug targets for treatment of tuberculosis identified.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- eXegenics, Inc. (EXEG) announced the demonstration that enzyme targets to which it has proprietary rights can serve in the development of drugs to fight tuberculosis, the world's most dangerous...

Ekips Technologies receives grant for development of asthma detection, treatment technology.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Patrick McCann, founder and president of Ekips Technologies, Inc., announced the company has received a $100,000 phase I grant from the National Science Foundation (NSF) for support of hardware and...

New treatment developed.(for colds)
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Scientists at the University of Virginia (UVa) have developed a new combination drug therapy that delivers a one-two punch to knock out colds. In study results reported in the current on-line issue of...

Neogen, Hamilton Thorne Biosciences to develop advanced testing products.(rapid food bacterial food safety tests)(Brief Article)
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Neogen Corp. (NEOG) and Hamilton Thorne Biosciences announced an agreement to jointly develop the next generation of rapid bacterial food safety tests. Under the agreement, Neogen will license...

Pseudotyped viral protein particles provide improved efficacy.(HIV-specific immune response)
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - HIV protein particles can trigger extensive HIV-specific immune responses when wrapped in the shell of a different virus, researchers in France report. "In...

Mojave Therapeutics wins patent for DNA-based antigen delivery system.(Brief Article)
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Mojave Therapeutics, Inc., a developer heat shock protein-based immunotherapies, announced that the U.S. Patent and Trademark Office has issued Patent No. 6,331,299, on its DNA-mediated Antigen Release...

MorphoSys, Roche announce major milestone in research collaboration.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- MorphoSys AG (MOR), a Munich-based biotechnology company, and Roche announced the achievement of an important milestone in their collaboration. In achieving the milestone MorphoSys generated and...

Protein Design Labs begins phase I trial of SMART Anti-IL-12 antibody.(for the treatment of autoimmune diseases)(Brief Article)
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Protein Design Labs, Inc., (PDLI) has initiated a phase I clinical trial to evaluate the safety and pharmacokinetics of its humanized SMART Anti-IL-12 antibody. The trial is a randomized, blinded,...

Roche receives approval in Europe for Tamiflu.
August 7, 2002... 2002 AUG 7 - (NewsRx.com & NewsRx.net) -- Roche and Gilead Sciences, Inc., (GILD) announced that Roche has received approval from the European authorities to market Tamiflu (oseltamivir phosphate) for the treatment of influenza in adults and...

Switch the key to disease breakthroughs on many fronts.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- A single molecular switch may be the key to fighting disease on several fronts. Research published in Science suggests that the blocking of one signaling pathway may be crucial in tackling autoimmune...

Most individuals with rheumatoid disease can be protected against hepatitis B.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- by Sonia Bell-Nichols, senior medical writer - A limited investigation of people with rheumatoid arthritis indicates that hepatitis B vaccine will be effective in more than half of those vaccinated....

Study suggests MDA-7/interleukin-24 protein plays key role in activating immune system against cancer.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- A preclinical study published in the Journal of Immunology suggests that the MDA-7/interleukin-24 (IL-24) protein plays an important role in the activation of the human immune system to fight cancer....

Measuring a specific immune response may aid in diagnosis.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- In a step that might eventually make colon cancer easier to detect and treat, a study published July 16, 2002, in the journal Cancer Research finds that the immune system naturally identifies the...

Bone marrow stem cells involved in pathogenesis.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic stem cells may play a key role in arthritis development, according to researchers in Japan. "Recent studies have suggested the involvement of...

ViroLogic study supports greater use of HIV drug resistance testing in newly infected patients.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- ViroLogic, Inc., (VLGC) announced that research published in this week's issue of the Journal of the American Medical Association (JAMA) and reported at the 14th Annual International AIDS Conference...

MorphoSys and Roche announce major milestone in research collaboration.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- MorphoSys AG (MOR), a Munich-based biotechnology company, and Roche announced the achievement of an important milestone in their collaboration. In achieving the milestone MorphoSys generated and...

Medline E*Kits now available with ChloraPrep Antiseptic.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Medline recently signed a Diamond Alliance supply agreement with Medi-Flex Hospital Products, Inc., in which Medline becomes a preferred supplier of ChloraPrep for Medline's E*Kits (efficiency kits),...

New long-term data confirm Protopic efficacy and safety.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- An international panel of speakers provided an in-depth, global update on clinical experience with Protopic (tacrolimus ointment) in children and adults suffering from moderate-to-severe atopic...

Study finds new Elidel Cream 1% reduces need for corticosteroids.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- A study published in the July issue of the journal Pediatrics shows that Elidel (pimecrolimus) Cream 1% significantly reduced the incidence of atopic dermatitis (also known as eczema) flares, as well...

Immune Response, Trinity, to restructure license and collaboration agreement.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced a significant restructuring of its Remune license and collaboration contract with Trinity Medical Group U.S.A., Inc., (TMGU). The amended contract...

deCODE, Elitra advance alliance to discover antibiotics to fight drug-resistant bacteria.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- deCODE genetics (DCGN) and Elitra Pharmaceuticals Inc. announced the initiation of medicinal chemistry work under their alliance to discover and develop new antibiotics to combat drug-resistant...

Genetic mutations in HIV that may cause resistance to new drug T-20 identified.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Visible Genetics, Inc., (VGIN) scientists have identified a number of new mutations in the HIV genetic code that may be making the virus resistant to T-20, the first of a new class of experimental...

European approval granted for Synvisc in the hip.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Genzyme Biosurgery (GZBX), a division of Genzyme Corp., announced that it has gained approval in the European Union to market Synvisc (Hylan G-F 20) for the treatment of osteoarthritis pain in the hip....

HuMax-IL15 is effective in mouse study.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that its human antibody therapeutic HuMax-IL15 effectively treated psoriasis in a mouse disease model. In this study, HuMax-IL15 was superior to cyclosporine A, considered the...

Immunex initiates second phase III pivotal study of Enbrel.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Immunex Corp. (IMNX) and Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced they have initiated a second, global phase III pivotal study assessing the efficacy and tolerability of Enbrel...

NicOx announces first clinical results for inhaled NCX 950.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- NicOx, S.A., (NICOX) announced positive phase I/II clinical results for the first administration into man of inhaled NCX 950. Results were presented during an official satellite of the XIVth World...

Immune Response to suspend reverse stock split and apply for Nasdaq SmallCap listing.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced its current intention to not implement a previously authorized one-for-four reverse stock split and to instead submit an application to the Nasdaq Stock...

Texas Biotechnology receives milestone payment from Schering-Plough.(Brief Article)
August 14, 2002... 2002 AUG 14 - (NewsRx.com & NewsRx.net) -- Texas Biotechnology Corp. (TXBI) announced that it had achieved a milestone in its collaboration with Schering-Plough Corp. (SGP) to discover and develop VLA-4 antagonist drugs to treat asthma. ...

Switch the key to disease breakthroughs on many fronts.
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- A single molecular switch may be the key to fighting disease on several fronts. Research published in Science suggests that the blocking of one signaling pathway may be crucial in tackling autoimmune...

Most individuals with rheumatoid disease can be protected against hepatitis B.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- by Sonia Bell-Nichols, senior medical writer - A limited investigation of people with rheumatoid arthritis indicates that hepatitis B vaccine will be effective in more than half of those vaccinated....

Study suggests MDA-7/interleukin-24 protein plays key role in activating immune system against cancer.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- A preclinical study published in the Journal of Immunology suggests that the MDA-7/interleukin-24 (IL-24) protein plays an important role in the activation of the human immune system to fight cancer....

Measuring a specific immune response may aid in diagnosis.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- In a step that might eventually make colon cancer easier to detect and treat, a study published July 16, 2002, in the journal Cancer Research finds that the immune system naturally identifies the...

Bone marrow stem cells involved in pathogenesis.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic stem cells may play a key role in arthritis development, according to researchers in Japan. "Recent studies have suggested the involvement of...

ViroLogic study supports greater use of HIV drug resistance testing in newly infected patients.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- ViroLogic, Inc., (VLGC) announced that research published in this week's issue of the Journal of the American Medical Association (JAMA) and reported at the 14th Annual International AIDS Conference...

MorphoSys and Roche announce major milestone in research collaboration.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- MorphoSys AG (MOR), a Munich-based biotechnology company, and Roche announced the achievement of an important milestone in their collaboration. In achieving the milestone MorphoSys generated and...

Medline E*Kits now available with ChloraPrep Antiseptic.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- Medline recently signed a Diamond Alliance supply agreement with Medi-Flex Hospital Products, Inc., in which Medline becomes a preferred supplier of ChloraPrep for Medline's E*Kits (efficiency kits),...

New long-term data confirm Protopic efficacy and safety.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- An international panel of speakers provided an in-depth, global update on clinical experience with Protopic (tacrolimus ointment) in children and adults suffering from moderate-to-severe atopic...

Study finds new Elidel Cream 1% reduces need for corticosteroids.
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- A study published in the July issue of the journal Pediatrics shows that Elidel (pimecrolimus) Cream 1% significantly reduced the incidence of atopic dermatitis (also known as eczema) flares, as well...

Immune Response, Trinity, to restructure license and collaboration agreement.(Trinity Medical Group USA Inc.)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced a significant restructuring of its Remune license and collaboration contract with Trinity Medical Group U.S.A., Inc., (TMGU). The amended contract...

deCODE, Elitra advance alliance to discover antibiotics to fight drug-resistant bacteria.(dCode Genetics, Elitra Pharmaceuticals Inc.)(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- deCODE genetics (DCGN) and Elitra Pharmaceuticals Inc. announced the initiation of medicinal chemistry work under their alliance to discover and develop new antibiotics to combat drug-resistant...

Genetic mutations in HIV that may cause resistance to new drug T-20 identified.
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- Visible Genetics, Inc., (VGIN) scientists have identified a number of new mutations in the HIV genetic code that may be making the virus resistant to T-20, the first of a new class of experimental...

European approval granted for Synvisc in the hip.(treatment of osteoarthritis in the hip)(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- Genzyme Biosurgery (GZBX), a division of Genzyme Corp., announced that it has gained approval in the European Union to market Synvisc (Hylan G-F 20) for the treatment of osteoarthritis pain in the hip....

HuMax-IL15 is effective in mouse study.(psoriasis treatment)(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that its human antibody therapeutic HuMax-IL15 effectively treated psoriasis in a mouse disease model. In this study, HuMax-IL15 was superior to cyclosporine A, considered the...

Immunex initiates second phase III pivotal study of Enbrel.(for the treatment of severe plaque psoriasis)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- Immunex Corp. (IMNX) and Wyeth Pharmaceuticals, a division of Wyeth (WYE), announced they have initiated a second, global phase III pivotal study assessing the efficacy and tolerability of Enbrel...

NicOx announces first clinical results for inhaled NCX 950.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- NicOx, S.A., (NICOX) announced positive phase I/II clinical results for the first administration into man of inhaled NCX 950. Results were presented during an official satellite of the XIVth World...

Immune Response to suspend reverse stock split and apply for Nasdaq SmallCap listing.(Brief Article)
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced its current intention to not implement a previously authorized one-for-four reverse stock split and to instead submit an application to the Nasdaq Stock...

Texas Biotechnology receives milestone payment from Schering-Plough.
August 21, 2002... 2002 AUG 21 - (NewsRx.com & NewsRx.net) -- Texas Biotechnology Corp. (TXBI) announced that it had achieved a milestone in its collaboration with Schering-Plough Corp. (SGP) to discover and develop VLA-4 antagonist drugs to treat asthma. ...

Standard medications not being used by up to 3/4 of those who most need them.(asthma therapy)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Only one-quarter to one-third of asthma patients who should be using standard anti-inflammatory medications are in fact using them. Lack of appropriate medication can result in poor asthma...

Exercise therapy may help.(to treat fibromyalgia)(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Prescribed graded aerobic exercise is a simple, cheap, and effective treatment for people with fibromyalgia (medically unexplained chronic muscular pain and joint tenderness), finds a study in the...

CWRU scientists demystify protein culprit.(Case Western Reserve University; arthritis treatment)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Researchers at Case Western Reserve University have discovered kinks in aggrecan, a widely studied protein at the submolecular root of arthritis, a finding that brings scientists closer toward new...

Breastfeeding at least 4 months decreases risk of asthma in infants.(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- According to a new study in the July 2002 Journal of Allergy and Clinical Immunology, exclusively breastfeeding infants for at least 4 months provided them protection from developing asthma. Maternal...

Net closes in on fish oil paradox: Why it helps some people but not others.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Not everyone can benefit from fish oil. Although it has been known for many years to relieve the symptoms of inflammatory diseases such as rheumatoid arthritis, its beneficial effects are not...

Gene therapy administered in utero cannot overcome postnatal immune response.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Animal model experiments suggest that administering gene therapy to fetuses while they are in the uterus does not mitigate their developing an immune response...

Nasonex indication expanded to include children as young as age 2.(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Schering-Plough Corp. (SGP) announced that the U.S. Food and Drug Administration (FDA) has approved the expansion of the indication of Nasonex (mometasone furoate monohydrate) for the treatment of...

deCODE announces discoveries in genetics and pharmacogenomics of asthma, allergy.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- deCODE genetics (DCGN) announced that its scientists have mapped the first gene ever shown to have genome-wide significant linkage to asthma. A paper describing the discovery, entitled "A major...

rhATIII PK study completed.(by GTC Biotherapeutics Inc.)(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- GTC Biotherapeutics, Inc., (GTC) has completed data gathering and analysis in the pharmacokinetic study of recombinant human antithrombin III (rhATIII) in patients with a hereditary deficiency of the...

Gary L. Davis named director of hepatology.(at Baylor University Medical Center)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Michael Emmett, MD, chief of internal medicine at Baylor University Medical Center has announced that Gary L. Davis, MD will serve as the director of the newly formed Division of Hepatology in the...

Valdecoxib receives positive opinion from E.U. board.(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Pharmacia Corp. (PHA) and Pfizer, Inc., announced that the Committee for Proprietary Medicinal Products (CPMP) adopted a positive opinion for granting marketing authorization for valdecoxib in the...

Symptomatic illness marks worse prognosis for autoimmune hepatitis patients.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- by Sonia Bell-Nichols, senior medical writer - Doctors don't know what leads to the onset of autoimmune hepatitis, but now they do know that being asymptomatic may offer patients a better outlook with...

Versicor expands agreement with Novartis to discover oral antibiotics.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Versicor, Inc., (VERS) announced that its ongoing collaboration with Novartis AG (NVS) related to the discovery and development of novel antibacterial agents has been extended. The collaboration...

Paratek patents second genetic target in fight against drug resistance.(Paratek Pharmaceuticals Inc.)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Paratek Pharmaceuticals, Inc., announced the issuance of U.S. Patent No. 6,346,391, entitled "Methods of Reducing Microbial Resistance to Drugs." The patent covers methods for inhibiting a new...

MedImmune reports results for first 6 months of 2002.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that total revenues for the first 6 months of 2002 increased 41% to $393 million from $279 million in the first 6 months of 2001. Product sales grew 43% during...

Antibody genes from patients induce broad antiviral activity.(HIV vaccine development)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Antibody genes from HIV patients could form the basis for an effective HIV vaccine, researchers in the United States report. "Although several human...

New drug for kidney dialysis patients introduced.(treatment of hyperphosphatemia)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Altair Nanotechnologies (ALTI) announced that it has used its patented nanoparticle process to develop a new pharmaceutical/new chemical entity (NCE) for the treatment of elevated phosphate levels in...

Pivotal U.S., European clinical trials begin for liquid immune globulin product.(Immune Globulin Intravenous 10% Solution)(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Baxter Healthcare Corporation announced that it has begun pivotal clinical trials in the United States and Europe for a new liquid immune globulin therapy, Immune Globulin Intravenous (Human), 10%...

Study of new ACE inhibitor treatment reported.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- GenoMed, Inc., (GMED) a St. Louis, Missouri-based medical genomics biotechnology company, announced that results of its novel ACE inhibitor treatment have been accepted for publication in the August...

Scientists explore role of COX-2 in fracture healing.
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Fracture or break a bone, and you pop an ibuprofen. Research being conducted at the University of Rochester Medical Center calls that common practice into question. In an article published in the...

Versicor, Pharmacia, expand agreement to discover oral antibiotics.(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- Versicor, Inc., (VERS) announced that an ongoing research collaboration with Pharmacia Corp. (PHA) related to the discovery and development of oral antibiotics has been extended by 3 years. The...

Immune Response Corp. wins patent for T-cell receptor peptide vaccine.(for psoriasis treatment)(Brief Article)
August 28, 2002... 2002 AUG 28 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced it was recently granted United States Patent No. 6,413,516 entitled "Peptides and Methods Against Psoriasis." The new patent includes composition and methods...